118 related articles for article (PubMed ID: 28045502)
1. Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates.
van Lith SA; van Duijnhoven SM; Navis AC; Leenders WP; Dolk E; Wennink JW; van Nostrum CF; van Hest JC
Bioconjug Chem; 2017 Feb; 28(2):539-548. PubMed ID: 28045502
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of camelid single-domain antibodies against HER2.
Hussack G; Raphael S; Lowden MJ; Henry KA
BMC Res Notes; 2018 Dec; 11(1):866. PubMed ID: 30518413
[TBL] [Abstract][Full Text] [Related]
3. Mirror-Image Single-Domain Antibody for a Novel Nonimmunogenic Drug Scaffold.
Aoki K; Manabe A; Kimura H; Katoh Y; Inuki S; Ohno H; Nonaka M; Oishi S
Bioconjug Chem; 2023 Nov; 34(11):2055-2065. PubMed ID: 37883660
[TBL] [Abstract][Full Text] [Related]
4. Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions.
Mullin M; McClory J; Haynes W; Grace J; Robertson N; van Heeke G
MAbs; 2024; 16(1):2341443. PubMed ID: 38666503
[TBL] [Abstract][Full Text] [Related]
5. Site-Specific Conjugation of Bottlebrush Polymers to Therapeutic Protein via Bioorthogonal Chemistry.
Saha B; Lee JH; Kwon I; Chung H
Biomacromolecules; 2024 May; 25(5):3200-3211. PubMed ID: 38591457
[TBL] [Abstract][Full Text] [Related]
6. Site-Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy.
Schwach J; Kolobynina K; Brandstetter K; Gerlach M; Ochtrop P; Helma J; Hackenberger CPR; Harz H; Cardoso MC; Leonhardt H; Stengl A
Chembiochem; 2021 Apr; 22(7):1205-1209. PubMed ID: 33207032
[TBL] [Abstract][Full Text] [Related]
7. Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles.
Park J; Chariou PL; Steinmetz NF
Bioconjug Chem; 2020 May; 31(5):1408-1416. PubMed ID: 32281790
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Production and Characterization of VHHs/Nanobodies Targeting Tau to Block Fibrillar Assembly.
Mortelecque J; Danis C; Landrieu I; Dupré E
Methods Mol Biol; 2024; 2754():131-146. PubMed ID: 38512665
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Potential Impact of In Silico Humanization on V
Martins C; Diharce J; Nadaradjane AA; de Brevern AG
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834033
[TBL] [Abstract][Full Text] [Related]
10. Sortase-tag expressed protein ligation: combining protein purification and site-specific bioconjugation into a single step.
Warden-Rothman R; Caturegli I; Popik V; Tsourkas A
Anal Chem; 2013 Nov; 85(22):11090-7. PubMed ID: 24111659
[TBL] [Abstract][Full Text] [Related]
11. Welding PROxAb Shuttles: A Modular Approach for Generating Bispecific Antibodies via Site-Specific Protein-Protein Conjugation.
Lehmann T; Schneider H; Tonillo J; Schanz J; Schwarz D; Schröter C; Jäger S; Kolmar H; Hecht S; Anderl J; Rasche N; Rieker M; Dickgiesser S
Bioconjug Chem; 2024 Jun; 35(6):780-789. PubMed ID: 38809610
[TBL] [Abstract][Full Text] [Related]
12. Application of strain-promoted azide-alkyne cycloaddition and tetrazine ligation to targeted Fc-drug conjugates.
Thomas JD; Cui H; North PJ; Hofer T; Rader C; Burke TR
Bioconjug Chem; 2012 Oct; 23(10):2007-13. PubMed ID: 22988967
[TBL] [Abstract][Full Text] [Related]
13. A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein.
Mortelecque J; Zejneli O; Bégard S; Simões MC; ElHajjar L; Nguyen M; Cantrelle FX; Hanoulle X; Rain JC; Colin M; Gomes CM; Buée L; Landrieu I; Danis C; Dupré E
J Biol Chem; 2024 Apr; 300(4):107163. PubMed ID: 38484799
[TBL] [Abstract][Full Text] [Related]
14. Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
Hashad RA; Jap E; Casey JL; Candace Ho YT; Wright A; Thalmann C; Sleeman M; Lupton DW; Hagemeyer CE; Cryle MJ; Robert R; Alt K
Chemistry; 2023 Feb; 29(11):e202202491. PubMed ID: 36451579
[TBL] [Abstract][Full Text] [Related]
15. Branched Polyhedral Oligomeric Silsesquioxane Nanoparticles Prepared via Strain-Promoted 1,3-Dipolar Cycloadditions.
Ledin PA; Xu W; Friscourt F; Boons GJ; Tsukruk VV
Langmuir; 2015 Jul; 31(29):8146-55. PubMed ID: 26131712
[TBL] [Abstract][Full Text] [Related]
16. Structure and development of single domain antibodies as modules for therapeutics and diagnostics.
Hoey RJ; Eom H; Horn JR
Exp Biol Med (Maywood); 2019 Dec; 244(17):1568-1576. PubMed ID: 31594404
[TBL] [Abstract][Full Text] [Related]
17. A Bioorthogonal Click Chemistry Toolbox for Targeted Synthesis of Branched and Well-Defined Protein-Protein Conjugates.
Baalmann M; Neises L; Bitsch S; Schneider H; Deweid L; Werther P; Ilkenhans N; Wolfring M; Ziegler MJ; Wilhelm J; Kolmar H; Wombacher R
Angew Chem Int Ed Engl; 2020 Jul; 59(31):12885-12893. PubMed ID: 32342666
[TBL] [Abstract][Full Text] [Related]
18. A versatile method for conjugating lipid nanoparticles on T cells through combination of click chemistry and metabolic glycoengineering.
Li X; Weller S; Clergeaud G; Andresen TL
Biotechnol J; 2024 Jan; 19(1):e2300339. PubMed ID: 38178719
[TBL] [Abstract][Full Text] [Related]
19. Site-selective orientated immobilization of antibodies and conjugates for immunodiagnostics development.
Shen M; Rusling J; Dixit CK
Methods; 2017 Mar; 116():95-111. PubMed ID: 27876681
[TBL] [Abstract][Full Text] [Related]
20. Orthogonally dual-clickable Janus nanoparticles via a cyclic templating strategy.
Zhang S; Li Z; Samarajeewa S; Sun G; Yang C; Wooley KL
J Am Chem Soc; 2011 Jul; 133(29):11046-9. PubMed ID: 21732605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
